adults will qualify as obese by 2030 and nearly 25% as severely obese.i GLP-1s should be a key tool in managing obesity outcomes and costs: Despite higher prescription costs relative to nonusers, persistent GLP-1 use can decrease average annual total cost of care by $14K-$15K (14%) among chronically obese patients in the first one to two years of use
Research shows GLP1R rs6923761 variants, MC4R rs17782313 polymorphisms, and FTO gene status correlate with variable appetite-suppression responses to GLP-1 agonists
A healthcare provider can help create a plan for achieving a healthy weight by: Gradually reducing Ozempic while adding natural alternatives Monitoring blood sugar, blood pressure, and cholesterol Following a balanced diet with fiber, lean proteins, and healthy fats to manage appetite Safety considerations for natural alternatives Natural Ozempic alternatives can be helpful but come with potential risks
Promotes wound healing and may reduce scarring (TB-500)
Therefore, we next explored whether modulating mitochondrial metabolism was sufficient to alter 5FU sensitivity